Mechanism of covalent adduct formation of aucubin to proteins

被引:45
作者
Kim, DH
Kim, BR
Kim, JY
Jeong, YC
机构
[1] Korea Inst Sci & Technol, Bioanal & Biotransformat Res Ctr, Seoul 136791, South Korea
[2] Won Kwang Univ, Dept Biochem, Sch Med, Iksan, South Korea
关键词
aucubin; serum albumin; covalent binding;
D O I
10.1016/S0378-4274(99)00295-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The iridoid glucoside aucubin can irreversibly bind to proteins through the formation of its aglycone. In view of a possible involvement of these protein adducts in the toxicity of aucubin, we investigated the mechanism of binding of aucubin to proteins. [H-3]aucubin in itself did not result in binding to protein whereas it covalently bound to rat serum albumin as a function of exposure time and dose in the presence of beta-glucosidase. The rate and extent of protein binding were significantly increased in the presence of the imine-trapping agent sodium cyanide. Oral administration of [H-3]aucubin to rats showed that the total radioactivity in plasma remained at a similar level for up to 6 h once peak level was reached, suggesting that a considerable amount of radioactivity might be covalently associated with plasma proteins. The levels of radioactivity in the liver and kidney after oral dosing were higher than those after i.v. dosing. These results indicate that the open-chain aglycone of aucubin can form an imine bond with a nucleophilic site of the protein and these irreversible bindings may partially contribute to its biological and toxic effects. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:181 / 188
页数:8
相关论文
共 25 条
[1]   INHIBITION OF P-450 BY AUCUBIN - IS THE BIOLOGICAL-ACTIVITY OF AUCUBIN DUE TO ITS GLUTARALDEHYDE-LIKE AGLYCONE [J].
BARTHOLOMAEUS, A ;
AHOKAS, J .
TOXICOLOGY LETTERS, 1995, 80 (1-3) :75-83
[2]  
BERNINI R, 1984, PHYTOCHEMISTRY, V23, P1431, DOI 10.1016/S0031-9422(00)80480-X
[3]   STRUCTURE OF EUCOMMIOL, A NEW CYCLOPENTENOID-TETROL FROM EUCOMMIA-ULMOIDES [J].
BIANCO, A ;
IAVARONE, C ;
TROGOLO, C .
TETRAHEDRON, 1974, 30 (23-2) :4117-4121
[4]   ACETAMINOPHEN HEPATOTOXICITY - CORRESPONDENCE OF SELECTIVE PROTEIN ARYLATION IN HUMAN AND MOUSE-LIVER INVITRO, IN CULTURE, AND INVIVO [J].
BIRGE, RB ;
BARTOLONE, JB ;
HART, SGE ;
NISHANIAN, EV ;
TYSON, CA ;
KHAIRALLAH, EA ;
COHEN, SD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 105 (03) :472-482
[5]  
BOBIT J, 1969, CYCLOPENTANOID TERPE, P3
[6]   SPECIFIC TARGETS OF COVALENT DRUG-PROTEIN INTERACTIONS IN HEPATOCYTES AND THEIR TOXICOLOGICAL SIGNIFICANCE IN DRUG-INDUCED LIVER-INJURY [J].
BOELSTERLI, UA .
DRUG METABOLISM REVIEWS, 1993, 25 (04) :395-451
[7]   PROTECTIVE ACTIVITIES OF AUCUBIN AGAINST CARBON TETRACHLORIDE-INDUCED LIVER-DAMAGE IN MICE [J].
CHANG, IM ;
RYU, JC ;
PARK, YC ;
YUN, HS ;
YANG, KH .
DRUG AND CHEMICAL TOXICOLOGY, 1983, 6 (05) :443-453
[8]  
Chang IM, 1998, RES COMMUN MOL PATH, V102, P189
[9]   THE QUANTITATIVE ISOLATION AND ANTIMICROBIAL ACTIVITY OF THE AGLYCONE OF AUCUBIN [J].
DAVINI, E ;
IAVARONE, C ;
TROGOLO, C ;
AURELI, P ;
PASOLINI, B .
PHYTOCHEMISTRY, 1986, 25 (10) :2420-2422
[10]   DISPOSITION AND IRREVERSIBLE PLASMA-PROTEIN BINDING OF TOLMETIN IN HUMANS [J].
HYNECK, ML ;
SMITH, PC ;
MUNAFO, A ;
MCDONAGH, AF ;
BENET, LZ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) :107-114